Chronic administration of haloperidol and olanzapine attenuates ketamine-induced brain metabolic activation

Journal of Pharmacology and Experimental Therapeutics

Volumn 305, Issue 3, 2003, Pages 999-1005

  Duncan, Gary E ^a   Miyamoto, Seiya ^a   Lieberman, Jeffrey A ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 14; DEOXYGLUCOSE; HALOPERIDOL; KETAMINE; OLANZAPINE;

ADAPTATION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN METABOLISM; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG MECHANISM; DRUG UPTAKE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANALGESICS; ANIMALS; ANTIPSYCHOTIC AGENTS; AUTORADIOGRAPHY; BENZODIAZEPINES; BRAIN; CLOZAPINE; DEOXYGLUCOSE; DRUG INTERACTIONS; HALOPERIDOL; KETAMINE; PIRENZEPINE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0038476518     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.048140     Document Type: Article

References (49)

1. Adams BW and Moghaddam B (2001) Effect of clozapine, haloperidol, or M100907 on phencyclidine-activated glutamate efflux in the prefrontal cortex. Biol Psychiatry 50:750-757.
2. Andersen MP and Pouzet B (2001) Effects of acute versus chronic treatment with typical or atypical antipsychotics on d-amphetamine-induced sensorimotor gating deficits in rats. Psychopharmacology 156:291-304.
3. Arvanov VL, Liang X, Schwartz J, Grossman S, and Wang RY (1997) Clozapine and haloperidol modulate N-methyl-D-aspartate- and non-N-methyl-D-aspartate receptor-mediated neurotransmission in rat prefrontal cortical neurons in vitro. J Pharmacol Exp Ther 283:226-234.
4. Arvanov VL and Wang RY (1999) Clozapine, but not haloperidol, prevents the functional hyperactivity of N-methyl-D-aspartate receptors in rat cortical neurons induced by subchronic administration of phencyclidine. J Pharmacol Exp Ther 289:1000-1006.
5. Bakshi VP and Geyer MA (1995) Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine. Psychopharmacology 122:198-201.
6. Bakshi VP, Swerdlow NR, and Geyer MA (1994) Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. J Pharmacol Exp Ther 271:787-794.
7. Baldessarini RJ, Centorrino F, Flood JG, Volpicelli SA, Huston-Lyons D, and Cohen BM (1993) Tissue concentrations of clozapine and its metabolites in the rat. Neuropsychopharmacology 9:117-124.
8. Bustos G, Abarca J, Forray MI, Gysling K, Bradberry CW, and Roth RH (1992) Regulation of excitatory amino acid release by N-methyl-D-aspartate receptors in rat striatum: in vivo microdialysis studies. Brain Res 585:105-115.
9. Chen AC and Gurling HM (1999) D2 dopamine receptor but not AMPA and kainate glutamate receptor genes show altered expression in response to long term treatment with trans- and cis-flupenthixol in the rat brain. Brain Res Mol Brain Res 68:14-21.
10. Cheng YF and Paalzow LK (1992) Linear pharmacokinetics of haloperidol in the rat. Biopharm Drug Dispos 13:69-76.
11. Cohen BD, Rosenbaum G, Luby ED, and Gottlieb JS (1962) Comparison of phencyclidine hydrochloride (sernyl) with other drugs: simulation of schizophrenic performance with phencyclidine hydrochloride (sernyl)lysergic acid diethylamide (LSD-25) and amobarbital (Amytal) sodium, II - symbolic and sequential thinking. Arch Gen Psychiatry 6:79-85.
12. Coyle JT (1996) The glutamatergic dysfunction hypothesis for schizophrenia. Harvard Rev Psychiatry 3:241-253.
13. Corbett R, Camacho F, Woods AT, Kerman LL, Fishkin RJ, Brooks K, and Dunn RW (1995) Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors. Psychopharmacology 120:67-74.
14. Duncan GE, Johnson KB, and Breese GR (1993) Topographic patterns of brain activity in response to swim stress: Assessment by 2-deoxyglucose uptake and expression of Fos-like immunoreactivity. J. Neurosci 13:3932-3943.
15. Duncan GE, Leipzig JN, Mailman RB, and Lieberman JA (1998a) Differential effects of clozapine and haloperidol on ketamine-induced brain metabolic activation. Brain Res 812:65-75.
16. Duncan GE, Miyamoto S, Gu HB, Lieberman JA, Koller BH, and Snouwaert JN (2002) Alterations in regional brain metabolism in genetic and pharmacological models of reduced NMDA receptor function. Brain Res 951:166-176.
17. Duncan GE, Miyamoto S, Leipzig JN, and Lieberman JA (2000) Comparison of the effects of clozapine, risperidone and olanzapine on ketamine-induced alterations in regional brain metabolism. J Pharmacol Exp Ther 293:8-14.
18. Duncan GE, Moy SS, Knapp DJ, Mueller RA, and Breese GR (1998b) Metabolic mapping of the rat brain after subanesthetic doses of ketamine: potential relevance to schizophrenia. Brain Res 787:181-190.
19. Farber NB, Kim SH, Dikranian K, Jiang XP, and Heinkel C (2002) Receptor mechanisms and circuitry underlying NMDA antagonist neurotoxicity. Mol Psychiatry 7:32-43.
20. Fitzgerald LW, Deutch AY, Gasic G, Heinemann SF, and Nestler EJ (1995) Regulation of cortical and subcortical glutamate receptor subunit expression by antipsychotic drugs. J Neurosci 15:2453-2461.
21. Geyer MA, Krebs-Thomson K, Braff DL, and Swerdlow NR (2001) Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology 156:117-154.
22. Giardino L, Bortolotti F, Orazzo C, Pozza M, Monteleone P, Calza L, and Maj M (1997) Effect of chronic clozapine administration on [3H]MK801-binding sites in the rat brain: a side-preference action in cortical areas. Brain Res 762:216-218.
23. Greene R (2001) Circuit analysis of NMDAR hypofunction in the hippocampus, in vitro and psychosis of schizophrenia. Hippocampus 11:569-577.
24. Jardemark KE, Liang X, Arvanov V, and Wang RY (2000) Subchronic treatment with either clozapine, olanzapine or haloperidol produces a hyposensitive response of the rat cortical cells to N-methyl-D-aspartate. Neuroscience 100:1-9.
25. Javitt DC and Zukin SR (1991) Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148:1301-1308.
26. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers MB Jr, and Charney DS (1994) Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive and neuroendocrine responses. Arch Gen Psychiatry 51:199-214.
27. Lahti AC, Holcomb HH, Medoff DR, and Tamminga CA (1995a) Ketamine activates psychosis and alters limbic blood flow in schizophrenia. Neuroreport 6:869-872.
28. Lahti AC, Koffel B, LaPorte D, and Tamminga CA (1995b) Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology 13:9-19.
29. Lahti AC, Weiler MA, Tamara MB, Parwani A, and Tamminga CA (2001) Effects of ketamine in normal and schizophrenic volunteers. Neuropsychopharmacology 25: 455-467.
30. Luby ED, Cohen BD, Rosenbaum G, Gottilieb JS, and Kelley R (1959) Study of a new schizophrenomimeitc drug-sernyl. Arch Neurol Psych 81:363-369.
31. Malhotra AK, Pinals DA, Adler CM, Elman I, Clifton A, Pickar D, and Breier A (1997) Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics. Neuropsychopharmacology 17:141-150.
32. Malhotra AK, Pinals DA, Weingartner H, Sirocco K, Missar CD, Pickar D, and Breier A (1996) NMDA receptor function and human cognition - the effects of ketamine in healthy volunteers. Neuropsychopharmacology 14:301-307.
33. Mansbach RS, Carver J, and Zorn SH (2001) Blockade of drug-induced deficits in prepulse inhibition of acoustic startle by ziprasidone. Pharmacol, Biochem Behav 69:535-542.
34. Martinez ZA, Oostwegel J, Geyer MA, Ellison GD, and Swerdlow NR (2000) "Early" and "late" effects of sustained haloperidol on apomorphine- and phencyclidine-induced sensorimotor gating deficits. Neuropsychopharmacology 23:517-527.
35. Miyamoto S, Leipzig JN, Lieberman JA, and Duncan GE (2000) Effects of ketamine, MK-801 and amphetamine on regional brain 2-deoxyglucose uptake in freely moving mice. Neuropsychopharmacology 22:400-412.
36. Miyamoto S, Mailman RB, Lieberman JA, and Duncan GE (2001) Blunted brain metabolic response to ketamine in mice lacking D(1A) dopamine receptors. Brain Res 894:167-180.
37. Moghaddam B, Adams B, Verman A, and Daly D (1997) Activation of glutamatergic neurotransmission by ketamine - a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 17:2921-2927.
38. Olney JW and Farber NB (1995) Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 52:998-1007.
39. Ossowska K (1995) The subsensitivity of striatal glutamate receptors induced by chronic haloperidol in rats. Eur J Pharmacol 294:685-691.
40. Ossowska K, Pietraszek M, Wardas J, Nowak G, and Wolfarth S (1999) Chronic haloperidol and clozapine administration increases the number of cortical NMDA receptors in rats. Naunyn-Schmiedebergs Arch Pharmacol 359:280-287.
41. Ossowska K, Pietraszek M, Wardas J, Nowak G, Zajaczkowski W, Wolfarth S, and Pilc A (2000) The role of glutamate receptors in antipsychotic drug action. Amino Acids 19:87-94.
42. Paxinos G and Watson C (1997) The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
43. Pietraszek M and Ossowska K (1998) Chronic treatment with haloperidol diminishes the phencyclidine-induced sensorimotor gating deficit in rats. Naunyn-Schmiedebergs Arch Pharmacol 357:466-471.
44. Riva MA, Tascedda F, Lovati E, and Racagni G (1997) Regulation of NMDA receptor subunit messenger RNA levels in the rat brain following acute and chronic exposure to antipsychotic drugs. Brain Res Mol Brain Res 50:136-142.
45. Tarazi FI, Florijn WJ, and Creese I (1996) Regulation of ionotropic glutamate receptors following subchronic and chronic treatment with typical and atypical antipsychotics. Psychopharmacology 128:371-379.
46. Tascedda F, Blom JM, Brunello N, Zolin K, Gennarelli M, Colzi A, Bravi D, Carra S, Racagni G, and Riva MA (2001) Modulation of glutamate receptors in response to the novel antipsychotic olanzapine in rats. Biol Psychiatry 50:117-122.
47. Tascedda F, Lovati E, Blom JM, Muzzioli P, Brunello N, Racagni G, and Riva MA (1999) Regulation of ionotropic glutamate receptors in the rat brain in response to the atypical antipsychotic seroquel (quetiapine fumarate). Neuropsychopharmacology 21:211-217.
48. Ulas J, Nguyen L, and Cotman CW (1993) Chronic haloperidol treatment enhances binding to NMDA receptors in rat cortex. Neuroreport 4:1049-1051.
49. Wang RY and Liang X (1998) M100907 and clozapine, but not haloperidol or raclopride, prevent phencyclidine-induced blockade of NMDA responses in pyramidal neurons of the rat medial prefrontal cortical slice. Neuropsychopharmacology 19:74-85.